Chromadex Corp CS (CDXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CDXC | INZY | RAPT | ||
| Company | Chromadex Corp CS | Inozyme Pharma Inc | Rapt Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.80 | 4.75 | 8.28 | ||
| High | 3.92 | 4.83 | 8.56 | ||
| Low | 3.71 | 4.68 | 8.15 | ||
| Last | 3.78 | 4.74 | 8.33 | ||
| Change | +0.02 | +0.09 | +0.20 | ||
| % Change | +0.53% | +1.94% | +2.52% | ||
| Volume | 121,773 | 327,045 | 421,375 | ||
| 20-Day Average Volume | 282,764 | 761,242 | 841,489 | ||
| Previous Close | 3.76 | 4.65 | 8.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.71 | 4.75 | 8.24 | ||
| 20-Day Raw Stochastic | 60.34% | 19.79% | 37.96% | ||
| 20-Day Relative Strength | 58.43% | 42.94% | 42.40% | ||
| Weighted Alpha | +115.14 | -18.77 | -5.24 | ||
| Today's Opinion | 96% Buy | 8% Buy | 88% Sell | ||
| Previous Opinion | 96% Buy | 8% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.88% since 04/26/24 | +6.76% since 04/26/24 | +2.84% since 04/26/24 | ||
| Low | 3.40 on 04/29/24 | 4.35 on 05/01/24 | 7.68 on 04/30/24 | ||
| High | 3.92 on 05/03/24 | 4.83 on 05/03/24 | 8.56 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -4.30% since 04/03/24 | -33.89% since 04/03/24 | -0.36% since 04/03/24 | ||
| Low | 2.89 on 04/22/24 | 4.18 on 04/25/24 | 7.52 on 04/25/24 | ||
| High | 4.65 on 04/05/24 | 7.31 on 04/04/24 | 9.65 on 04/11/24 | ||
| 3-Month | |||||
| %Chg | +148.68% since 02/02/24 | -10.73% since 02/02/24 | -66.57% since 02/02/24 | ||
| Low | 1.46 on 02/12/24 | 4.18 on 04/25/24 | 6.86 on 02/20/24 | ||
| High | 4.65 on 04/05/24 | 7.80 on 04/01/24 | 27.35 on 02/12/24 | ||
| 6-Month | |||||
| %Chg | +155.41% since 11/03/23 | +49.06% since 11/03/23 | -46.26% since 11/03/23 | ||
| Low | 1.32 on 12/13/23 | 2.71 on 11/13/23 | 6.86 on 02/20/24 | ||
| High | 4.65 on 04/05/24 | 7.80 on 04/01/24 | 27.35 on 02/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 283,970 | 287,630 | 282,750 | ||
| Shares Outstanding, K | 75,524 | 61,856 | 34,800 | ||
| Annual Sales | 83,570,000 | 0 | 0 | ||
| Annual Net Income | -4,940,000 | -71,170,000 | -116,800,000 | ||
| Last Quarter Sales | 21,200,000 | 0 | 0 | ||
| Last Quarter Net Income | 110,000 | -21,540,000 | -30,880,000 | ||
| 60-Month Beta | 1.96 | 1.54 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/06/24 | -0.35 on 03/12/24 | -0.80 on 03/07/24 | ||
| Latest Earnings Date | 05/08/24 | 05/14/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||